These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8823511)

  • 1. Microbial biotransformation products of cyclosporin A.
    Kuhnt M; Bitsch F; France J; Hofmann H; Sanglier JJ; Traber R
    J Antibiot (Tokyo); 1996 Aug; 49(8):781-7. PubMed ID: 8823511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human metabolites of cyclosporin A, AM1, AM 4 N and AM 9, by microbial conversion.
    Ohta K; Agematu H; Yamada T; Kaneko K; Tsuchida T
    J Biosci Bioeng; 2005 Apr; 99(4):390-5. PubMed ID: 16233807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin G inhibits proliferation of A431 cells in a dose- and time-dependent manner comparable to cyclosporin A.
    Teofoli P; De Pità O; Lotti TM
    Skin Pharmacol; 1997; 10(2):79-84. PubMed ID: 9257376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose.
    Molpeceres J; Chacón M; Guzmán M; Aberturas MR; Berges L
    Int J Pharm; 2000 Mar; 197(1-2):129-41. PubMed ID: 10704800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC-ESI-ion trap-mass spectrometry.
    Ahn EY; Shrestha A; Hoang NH; Huong NL; Yoon YJ; Park JW
    Talanta; 2014 Jun; 123():89-94. PubMed ID: 24725868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene disruption and functional complementation of cytochrome P450 Hydroyxlase involved in cyclosporin A hydroxylation in Sebekia benihana.
    Lee MJ; Han K; Kim ES
    J Microbiol Biotechnol; 2011 Jan; 21(1):14-9. PubMed ID: 21301187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial conversion products of leptomycin B.
    Kuhnt M; Bitsch F; Ponelle M; Sanglier JJ; Wang Y; Wolff B
    Appl Environ Microbiol; 1998 Feb; 64(2):714-20. PubMed ID: 9464413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.
    Fricker G; Drewe J; Huwyler J; Gutmann H; Beglinger C
    Br J Pharmacol; 1996 Aug; 118(7):1841-7. PubMed ID: 8842452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
    Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
    Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
    Ugazio E; Cavalli R; Gasco MR
    Int J Pharm; 2002 Jul; 241(2):341-4. PubMed ID: 12100861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial transformation of cycloastragenol.
    Kuban M; Öngen G; Khan IA; Bedir E
    Phytochemistry; 2013 Apr; 88():99-104. PubMed ID: 23357596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver.
    Delle Monache MD; Gigliozzi A; Benedetti A; Marucci L; Bini A; Francia C; Papa E; Di Cosimo E; Fraioli F; Jezequel AM; Alvaro D
    Dig Dis Sci; 1999 Nov; 44(11):2196-204. PubMed ID: 10573362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal formulations of Cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics.
    Fahr A; Seelig J
    Crit Rev Ther Drug Carrier Syst; 2001; 18(2):141-72. PubMed ID: 11325030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of the In Vitro Activity of the Cyclosporine-Specific P450 Hydroxylase from Sebekia benihana and Development of a Heterologous Whole-Cell Biotransformation System.
    Ma L; Du L; Chen H; Sun Y; Huang S; Zheng X; Kim ES; Li S
    Appl Environ Microbiol; 2015 Sep; 81(18):6268-75. PubMed ID: 26150455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
    Tanaka C; Kawai R; Rowland M
    Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
    Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Kosoglou T; Greenberg HE; Kraft WK; Frick G; Murphy G; Gottesdiener K; Paolini JF
    J Clin Pharmacol; 2006 Mar; 46(3):321-7. PubMed ID: 16490808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanisms of biotransformation of p-tert-amylphenol by bacteria and fungi with special degradation abilities and simultaneous detoxification of the disinfectant.
    Schlueter R; Röder A; Czekalski N; Gliesche D; Mikolasch A; Schauer F
    Appl Microbiol Biotechnol; 2014 Jan; 98(1):373-84. PubMed ID: 24158734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
    Pescovitz MD; Wong RL; Choc MG; Chang CT
    Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin in steroid-resistant nephrotic syndrome.
    Adhikari M; Coovadia HM
    S Afr Med J; 1994 Nov; 84(11):753-6. PubMed ID: 7495012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial biotransformation of bioactive and clinically useful steroids and some salient features of steroids and biotransformation.
    Sultana N
    Steroids; 2018 Aug; 136():76-92. PubMed ID: 29360535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.